Transcription of EASL Clinical Practice Guidelines: The diagnosis …
{{id}} {{{paragraph}}}
EASL Clinical Practice guidelines : The diagnosis and managementof patients with primary biliary cholangitisqEuropean Association for the Study of the Liver SummaryPrimary biliary cholangitis (PBC) is a chronic inflammatoryautoimmune cholestatic liver disease, which when untreated willculminate in end-stage biliary cirrhosis. diagnosis is usuallybased on the presence of serum liver tests indicative of a chole-static hepatitis in association with circulating antimitochondrialantibodies. Patient presentation and course can be diverse andrisk stratification is important to ensure all patients receive a per-sonalised approach to their care. The goals of treatment and man-agement are the prevention of end-stage liver disease, and theamelioration of associated symptoms. Pharmacologic approachesin Practice , to reduce the impact of the progressive nature ofdisease, currently include licensed therapies (ursodeoxycholicacid and obeticholic acid) and off-label therapies (fibric acidderivatives, budesonide).
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitisq European Association for the Study of the Liver⇑
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Practice Guidelines for the Diagnosis, Guidelines, Practice Guidelines for the Diagnosis and Management, AAGL Practice Report: Practice Guidelines, AAGL Practice Report: Practice Guidelines for the Diagnosis and Management, Practice, Diagnosis and, Diagnosis and Management, For the Diagnosis and Management, NCCN Clinical Practice Guidelines in Oncology